Fashion designer and former Spice Girl Victoria Beckham has taken Sydney-based skincare company VB Skinlab to court, alleging it attempted to register two trade marks to trade off the reputation of her ‘VB’ marks.
As the world fights the COVID-19 pandemic IP offices around the world, like IP Australia, are accommodating the current reality. As with courts and other governmental institutions, these offices have adopted measures such as relaxing statutory deadlines and handling matters in accordance with social distancing practices. But there are several important points to observe in terms of engaging with IP Australia during this time, writes Gilbert + Tobin’s Lisa Lennon, John Lee, Chris Williams, Mindaugas Skavronskas and Sidney Kung.
Two Italian cheese consortiums have failed in separate bids to trade mark their respective cheeses, Gorgonzola and Asiago, with delegates ruling the trade marks were not capable of distinguishing each consortiumās products from other cheeses.
Kraft has lost an appeal in its high-stakes legal battle against Bega over the right to use its distinctive peanut butter trade dress in Australia.
Fashion designer Victoria Beckham has lost her opposition to two trade marks owned by Sydney-based skincare company VB Skinlab, despite IP Australia finding the former Spice Girl’s VB marks have a reputation in Australia.
Pop star Katy Perry has won her bid to split up the trial in high-stakes litigation with a Sydney-based fashion designer over who owns the rights to the ‘Katy Perry’ name in Australia.
A judge has dismissed an opposition by tech company Vehicle Management Systems to a patent application by rival SARB Management Group for an integrated magnetic parking overstay detector.
Nappy maker Rascal + Friends has brought a lawsuit seeking to invalidate a patent held by Japanese competitor Uni-Charm.
The judge overseeing the trial in a trade secrets case brought by Australian auto electronics developer Directed Electronics OE against its rivals is considering how the cross-examination of witnesses will proceed given current restrictions imposed on gatherings due to the coronavirus, including in the event of a possible lockdown.
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.